Omico’s development and growth in precision oncology, recently boosted by significant funding in the 2026-27 Budget, is also producing a substantial library of patient-level data that demonstrates that genomic profiling of tumours changes lives and could reshape how Australia funds and delivers cancer care. …
Omico is evolving tumour genomics into hard evidence for precision oncology
June 8, 2026 Latest NewsBioPharma
Latest Video
New Stories
-
If this is an example of a bully playing hardball, it's not the companies
July 21, 2026 - - Latest News -
LTR Pharma secures national US manufacturing and fulfilment partner
July 21, 2026 - - Latest News -
Candidate shows antidepressant signal in difficult to treat depression
July 21, 2026 - - Latest News -
'Our access. Our medicines. Our vaccines. Our medical technology'
July 21, 2026 - - Latest News -
Novartis names Anne Harris to lead Australia and New Zealand
July 20, 2026 - - Latest News -
Why is the system slower than when there was no patient involvement or input?
July 20, 2026 - - Latest News -
No company in its right mind would risk a large private market for this outcome?
July 20, 2026 - - Latest News